[Clinical evaluation of GV-523 for severe infections complicating hematopoietic diseases--a comparative study using the cross-over method. Hematopoietic Disease Study Group for GV-523].

HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

[Clinical evaluation of GV-523 for severe infections complicating hematopoietic diseases--a comparative study using the cross-over method. Hematopoietic Disease Study Group for GV-523].

Authors	T Masaoka, H Shibata, K Nagai, A Kanamaru, T Yonezawa, Y Kanayama, T Kitani, N Taniguchi, A Horiuchi, H Hasegawa
Journal	Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases (Kansenshogaku Zasshi) Vol. 59 Issue 11 Pg. 1041-55 (Nov 1985) ISSN: 0387-5911 [Print] JAPAN
PMID	2420906 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article)
Chemical References	Drug Combinations Immunoglobulins, Intravenous gamma-Globulins Fibrinolysin
Topics	Adolescent Adult Aged Clinical Trials as Topic Drug Combinations (administration & dosage) Female Fibrinolysin (administration & dosage) Hematologic Diseases (complications) Humans Immunoglobulins, Intravenous Infection (therapy) Male Middle Aged Sepsis (therapy) gamma-Globulins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research network!